HLA-DQA1*05 GENOTYPE AND ANTI-TNF IMMUNOGENICITY: A SYSTEMATIC REVIEW AND META-ANALYSIS

被引:0
|
作者
Solitano, Virginia
Facciorusso, Antonio
Nguyen, Tran M.
Colman, Ruben J.
Zou, Lily
Boland, Brigid S.
Syversen, Silje W.
Joergensen, Kristin K.
Ma, Christopher
Armuzzi, Alessandro
Wilson, Aze
Jairath, Vipul
Singh, Siddharth
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Sa1806
引用
收藏
页码:S439 / S439
页数:1
相关论文
共 50 条
  • [21] Influence of HLA-DQA1*05 on the loss of response to anti-TNF treatment in inflammatory bowel disease. Spanish cohort of real clinical practice
    Perez, Jorge Perez
    Ortiz, Jaime Escobar
    Moreno, Ana Isabel Franco
    Santos, Maria del Rocio Plaza
    Pradillo, Marta Castillo
    Diaz, angel Ponferrada
    GASTROENTEROLOGIA Y HEPATOLOGIA, 2024, 47 (08): : 869 - 871
  • [22] HLA-DQA1*05 Was Not Associated With Primary Nonresponse or Loss of Response to First Anti-TNF in Real-World Inflammatory Bowel Disease Patients
    Pascual-Oliver, Andrea
    Casas-Deza, Diego
    Cuaran, Camila
    Garcia-Lopez, Santiago
    Corsino-Roche, Pilar
    Sierra-Moros, Eva
    Olier-Martinez, Pilar
    Gonzalez-Tarancon, Ricardo
    Vicente-Lidon, Raquel
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (06) : 922 - 929
  • [23] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [24] Influence of HLA DQA1*05 genotype in patients with inflammatory bowel disease and Anti-TNF treatment with proactive therapeutic drug monitoring
    Fuentes-Valenzuela, E.
    Garcia-Alonso, F. J.
    Maroto-Martin, C.
    Juan-Casamayor, L.
    Garrote Adrados, J. A.
    Almendros Munoz, R.
    de Prado, A.
    Marinero, M. A.
    Calleja Carbajosa, R.
    Vara Castrodeza, A.
    Barrio, J.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I369 - I370
  • [25] HLA-DQA1*05 IS ASSOCIATED WITH HIGHER RATES OF ANTIBODY FORMATION AND LOWER SERUM DRUG LEVELS IN INFLAMMATORY BOWEL DISEASE PATIENTS TREATED WITH ANTI-TNF AGENTS
    Gu, Cihang
    Naseer, Maliha
    Pabla, Baldeep S.
    Dalal, Robin
    Beaulieu, Dawn
    Schwartz, David A.
    Horst, Sara N.
    Scoville, Elizabeth A.
    GASTROENTEROLOGY, 2022, 162 (07) : S809 - S810
  • [26] Safety of Anti-TNF Treatment in Liver Transplant Recipients: A Systematic Review and Meta-analysis
    van Meeteren, M. J. Westerouen
    Hayee, B.
    Inderson, A.
    van der Meulen, A. E.
    Altwegg, R.
    van Hoek, B.
    Pageaux, G. P.
    Stijnen, T.
    Stein, D.
    Maljaars, P. W. J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (09): : 1146 - 1151
  • [27] Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis
    Bek, S.
    Bojesen, A. B.
    Nielsen, J. V.
    Sode, J.
    Bank, S.
    Vogel, U.
    Andersen, V.
    PHARMACOGENOMICS JOURNAL, 2017, 17 (05): : 403 - 411
  • [28] Safety of anti-TNF treatment in older IBD patients: a systematic review and meta-analysis
    Waars, S.
    Dekkers, N.
    van der Meulen, A.
    Stijnen, T.
    Maljaars, J.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S248 - S248
  • [29] Anti-TNF Alpha and Risk of Lymphoma in Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
    Imam, Ahmad A.
    MEDICINA-LITHUANIA, 2024, 60 (07):
  • [30] Systematic review and meta-analysis: pharmacogenetics of anti-TNF treatment response in rheumatoid arthritis
    S Bek
    A B Bojesen
    J V Nielsen
    J Sode
    S Bank
    U Vogel
    V Andersen
    The Pharmacogenomics Journal, 2017, 17 : 403 - 411